Smárason A K, Sargent I L, Redman C W
Harris Birthright Pre-eclampsia Research Unit, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, United Kingdom.
Am J Obstet Gynecol. 1996 Feb;174(2):787-93. doi: 10.1016/s0002-9378(96)70466-0.
Evidence has been sought for a circulating factor derived from the placenta that suppresses endothelial cell proliferation and hence contributes to the maternal endothelial cell disturbances of preeclampsia.
The effects of sera and plasmas from women with proteinuric preeclampsia and from matched normal pregnant control women on endothelial cell proliferation were compared. The recovery of endothelial cell inhibitory activity from syncytiotrophoblast microvesicles added to male blood and prepared as plasma or serum was determined to investigate the possible placental origin of the inhibitory factor.
Sera from women with preeclampsia did not inhibit endothelial cell proliferation. In contrast, plasma from preeclamptic women significantly suppressed endothelial cell growth at 20% dilution compared with controls, and suppression was more pronounced in severe preeclampsia. The inhibitory activity of syncytiotrophoblast microvesicles added to blood could not be recovered from serum, only from plasma, which may explain why there was no suppression with sera from preeclamptic women.
These results confirm that there is a blood-borne endothelial cell suppressive factor in preeclampsia that may be derived from the placenta.
探寻是否存在一种源自胎盘的循环因子,该因子可抑制内皮细胞增殖,进而导致子痫前期孕妇的内皮细胞紊乱。
比较了蛋白尿性子痫前期妇女及配对的正常妊娠对照妇女的血清和血浆对内皮细胞增殖的影响。为研究抑制因子可能的胎盘来源,测定了添加到男性血液中并制备成血浆或血清的合体滋养层微泡中内皮细胞抑制活性的恢复情况。
子痫前期妇女的血清未抑制内皮细胞增殖。相比之下,子痫前期妇女的血浆在20%稀释度时显著抑制内皮细胞生长,与对照组相比,重度子痫前期的抑制作用更明显。添加到血液中的合体滋养层微泡的抑制活性无法从血清中恢复,只能从血浆中恢复,这可能解释了为什么子痫前期妇女的血清没有抑制作用。
这些结果证实子痫前期存在一种可能源自胎盘的血源性内皮细胞抑制因子。